条件を指定して検索しています。すべての条件を解除する
アバスチンの副作用として、血圧が上がることはありますか? - 中外製薬
- https://www.chugai-pharm.co.jp
- faq
- blood_pressure
- https://www.chugai-pharm.co.jp
- faq
- blood_pressure
2024/2/2 -アバスチンによる治療を行うことで、高血圧があらわれることがあります1)。また、急激に血圧が上がる可能性もあります。アバスチンによる治療が開始されましたら、定期的 ...
アバスチンの副作用として、熱がでる、さむけ、咳(せき)や痰 ...
- https://www.chugai-pharm.co.jp
- avastin
- faq
- infection
- https://www.chugai-pharm.co.jp
- avastin
- faq
- infection
2024/2/11 -アバスチンの治療による骨髄抑制の副作用については「アバスチンによる副作用として、熱がでる、青あざができる、出血が止まりにくい、息切れなどの症状がでることが ...
Avastin (bevacizumab) - Roche
- https://www.roche.com
- solutions
- pharma
- https://www.roche.com
- solutions
- pharma
7時間前 -Avastin is approved in Japan for the treatment of the advanced stages of colorectal cancer, non-small cell lung cancer, breast cancer, ovarian cancer and ...
Avastin (bevacizumab): What to Expect, Side Effects, and More
- https://www.breastcancer.org
- targeted-therapy
- avastin
- https://www.breastcancer.org
- targeted-therapy
- avastin
2024/3/22 -Avastin is a targeted therapy that may be used off-label in combination with Taxol to treat certain people with metastatic HER2-negative breast cancer.
Bevacizumab - EyeWiki - American Academy of Ophthalmology
- https://eyewiki.aao.org
- Bevacizumab
- https://eyewiki.aao.org
- Bevacizumab
2024/2/13 -Bevacizumab (Avastin; manufactured in the United States by Genentech/Roche) is a recombinant humanized monoclonal IgG1 antibody that binds to and inhibits ...
2024/1/10 -切除不能肝細胞癌(T2N0M1 Stage IVB)に対しアテゾリズマブ・ベバシズマブ併用療法を開始し,2コース施行後のCTにて肝内病変の縮小を認めた.治療開始5カ月後に鼻出血が ...
2024/1/15 -Avastin, Alymsys, Mvasi, Avzivi, Vegzelma, or Zirabev, in combination with intravenous fluorouracil-based chemotherapy, is indicated for the first- or second- ...
Vascular Endothelial Growth Factor (VEGF) Inhibitors - UHCprovider.com
- https://www.uhcprovider.com
- comm-medical-drug
- https://www.uhcprovider.com
- comm-medical-drug
2024/4/1 -Coverage for Avastin®, Cimerli™, Eylea®, Lucentis®, and Vabysmo™ is contingent on criteria in the General Requirements and Diagnosis-Specific Requirements ...
EO2401 Plus Nivolumab and Bevacizumab Shows Activity in ...
- https://www.onclive.com
- view
- eo2401-plus-nivoluma...
- https://www.onclive.com
- view
- eo2401-plus-nivoluma...
2023/11/20 -The use of the first-in-class, microbiome-derived therapeutic vaccine EO2401 in combination with nivolumab (Opdivo) with or without bevacizumab (Avastin) ...
Colorectal metastatic capecitabine and beVACizumab - eviQ
- https://www.eviq.org.au
- colorectal
- metastatic
- 1175-c...
- https://www.eviq.org.au
- colorectal
- metastatic
- 1175-c...
2024/1/31 -Avastin® (bevacizumab) is no longer available on the PBS and alternative biosimilars are now available. The rapid infusion administration instructions for ...